Key Developments: Cynosure Inc (CYNO.OQ)

CYNO.OQ on NASDAQ Stock Exchange Global Select Market

31 Oct 2014
Price Change (% chg)

$0.36 (+1.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

Cynosure Inc Receives Expanded FDA clearance to market picosure for treatment of wrinkles
Wednesday, 24 Sep 2014 08:30am EDT 

Cynosure Inc:Receives FDA 510 clearance to market its flagship PicoSure Picosecond Laser Workstation for treatment of wrinkles with the company's new disposable energy delivery system, the FOCUS lens array.  Full Article

Cynosure Inc acquires assets of Ellman International Inc
Monday, 8 Sep 2014 07:30am EDT 

Cynosure Inc:Acquires assets of Ellman International, Inc. for about $13.2 million in cash.Transaction is expected to be accretive to Cynosure's earnings per share by the first quarter of 2015.  Full Article

Cynosure Inc appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President
Wednesday, 30 Jul 2014 08:30am EDT 

Cynosure Inc:Says it has promoted Executive Vice President, Chief Operating Officer and Chief Financial Officer Timothy W. Baker to President of the company, effective Aug. 1.Baker continue to serve as CFO and will take the title of President from Michael Davin, who remains Chairman and Chief Executive Officer.  Full Article

Cynosure Inc receives expanded FDA clearance to Market PicoSure for Treatment of Acne Scars
Thursday, 24 Jul 2014 08:30am EDT 

Cynosure Inc:Announced that it has received FDA 510 clearance to market its PicoSure Picosecond Laser Workstation for the treatment of acne scars with the FOCUS lens array, the company's new disposable energy delivery system.  Full Article

El En SpA sells 1.10 million Cynosure Inc shares for $32 million
Friday, 21 Mar 2014 03:46am EDT 

El En SpA:Announces that it has sold a block of 1.10 million of its shares of Cynosure Inc, at the net price of $29.15 per share for a total amount of $32 million.  Full Article

Cynosure Inc announces settlement of patent infringement lawsuits against Tria Beauty Inc
Monday, 16 Dec 2013 04:01pm EST 

Cynosure Inc:Says it will receive $10 mln plus future royalty payments under a comprehensive settlement agreement with Tria Beauty Inc. that ends the patent infringement litigation between Tria and Palomar Medical Technologies, which Cynosure acquired in June 2013.  Full Article

Cynosure Inc announces sale of burlington, MA office building
Monday, 2 Dec 2013 08:50am EST 

Cynosure Inc:Says it has sold the former Palomar Medical Technologies headquarters, a 130,000-square-foot, three-story building at 15 Network Drive in Burlington, MA, to Network Drive Owner, LLC.Says after paying transactions costs, Cynosure expects proceeds of the sale to be approximately $25.1 million.Says in connection with the transaction, Cynosure entered into a lease agreement with the buyer to occupy the building on a rent-free basis until June 30, 2014.  Full Article

Cynosure Inc Announces Resignation of President-Form 8-K
Friday, 6 Sep 2013 04:04pm EDT 

Cynosure Inc reported in its Form 8-K that on September 6, 2013, Joseph P. Caruso resigned as Vice Chairman and as a member of the Board of Directors and as President of the Company.  Full Article

Cynosure Inc Receives Health Canada Authorization To Market Picosure, The First Picosecond Laser To Remove Tattoos And Benign Pigmented Lesions
Monday, 29 Jul 2013 08:35am EDT 

Cynosure Inc announced that it has received a medical device license issued by Health Canada for the Company's PicoSure Picosecond Laser Workstation. Cynosure plans to begin selling PicoSure through its North American direct sales force immediately. The device received 510(k) clearance from the U.S. Food and Drug Administration at the end of 2012 and was launched in the first quarter of 2013. PicoSure received CE Mark certification in first quarter of 2013, and is currently being marketed in the European Union.  Full Article

Cynosure Inc Completes Acquisition Of Palomar Medical Technologies Inc
Monday, 24 Jun 2013 04:40pm EDT 

Cynosure Inc announced that the completion of its acquisition of Palomar Medical Technologies Inc Cynosure purchased Palomar in a cash and stock transaction valued at approximately $287 million. In the transaction, Cynosure issued approximately six million shares and paid approximately $146 million in cash contributed by both Cynosure and Palomar. The closing of the transaction follows approvals by Cynosure stockholders and Palomar stockholders at separate stockholders' meetings today. At the Cynosure stockholders' meeting, Cynosure stockholders approved the issuance of shares of Cynosure Class A common stock in the merger. At the Palomar stockholders' meeting, Palomar stockholders adopted the merger agreement between the companies. Under the terms of the agreement, each outstanding share of Palomar common stock converted into the right to receive $6.825 in cash and 0.2819 shares of Cynosure Class A common stock.  Full Article

Search Stocks